Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk

Recent advances in proteomic technologies have made high-throughput profiling of low-abundance proteins in large epidemiological cohorts increasingly feasible. We investigated whether aptamer-based proteomic profiling could identify biomarkers associated with future development of type 2 diabetes (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngo, Debby, Benson, Mark D., Long, Jonathan Z., Chen, Zsu-Zsu, Wang, Ruiqi, Nath, Anjali K., Keyes, Michelle J., Shen, Dongxiao, Sinha, Sumita, Kuhn, Eric, Morningstar, Jordan E., Shi, Xu, Peterson, Bennet D., Chan, Christopher, Katz, Daniel H., Tahir, Usman A., Farrell, Laurie A., Melander, Olle, Mosley, Jonathan D., Carr, Steven A., Vasan, Ramachandran S., Larson, Martin G., Smith, J. Gustav, Wang, Thomas J., Yang, Qiong, Gerszten, Robert E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021115/
https://www.ncbi.nlm.nih.gov/pubmed/33591955
http://dx.doi.org/10.1172/jci.insight.144392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021115/
https://www.ncbi.nlm.nih.gov/pubmed/33591955
http://dx.doi.org/10.1172/jci.insight.144392

Ejemplares similares